Valued at a market cap of $18.2 billion, Quest Diagnostics Incorporated (DGX) provides diagnostic testing and services in the ...

The global personal genome testing market is on a remarkable growth trajectory, projected to soar to USD 4,468 million by 2032, up from USD 1,545.5 million in 2022. This growth reflects a robust CAGR ...

Redburn Atlantic began coverage on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a report issued on Wednesday morning, MarketBeat reports. The firm issued a buy rating and a $195.00 price ...

Shares of Quest Diagnostics Inc. DGX slid 3.78% to $164.18 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 5.97% to 5,074.08 ...

Workers at Lifelabs on Victoria St. are now part of a province-wide strike against their American employer, Quest Diagnostics ...

The assays measure phosphorylated tau 181 and apolipoprotein 4 to rule out whether a patient has Alzheimer's disease.

PRINCE GEORGE – As part of a series of rotating strikes across the province, LifeLabs workers in Prince George went on strike ...

REGINA — Saskatchewan's health minister says he can't pull the plug on a contract with an American company offering lab ...

Quest Diagnostics Incorporated's ( NYSE:DGX ) dividend will be increasing from last year's payment of the same ...

Readers hoping to buy Quest Diagnostics Incorporated (NYSE:DGX) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is one business ...

Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy recommendation. Analyst Price Forecast Suggests 7.56% Upside As of March 19, 2025, ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced a new solution aimed at broadening access to human papillomavirus (HPV) screening to help identify women who ...